Jiangsu Aosaikang Pharmaceutical Co., Ltd.
USPTO PatentsView assignee record - 13 granted patents across 13 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Jiangsu ranks #21,309 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 13 technology areas.
- #21,309
- of 49,997 US assignees by volume
- 44th percentile
- by Innovation Score (33.2/100)
- 12.5
- avg claims per patent
- +1000%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R21309 · Foreign Corporation #21,309 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 13 grants
- MID-PACK #21,309/49,997
- PHOTO-FINISH Isola USA
- CPC-FOCUS A61P · 13 areas
- INNOV-THIN 33.2/100
- CLAIMS-RICH 12.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +1000% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Isola USA Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Jiangsu’s 33.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Jiangsu
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Jiangsu Aosaikang… · this assignee 33
Jiangsu Aosaikang… · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Jiangsu's Innovation Score is 33.2/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Jiangsu?
Each dot is one of Jiangsu’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jiangsu’s own 12.5 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Jiangsu's grants concentrate
Jiangsu Aosaikang Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 61.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2018. By volume, Jiangsu sits between Isola USA Corp. and Joint Stock Company “ATOMENERGOPROEKT”.
Jiangsu's three-year grant acceleration
Jiangsu Aosaikang Pharmaceutical Co., Ltd. shows 4 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Jiangsu's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Isola USA
Isola USA Corp.
13 patents
- J&M Shuler Medical
J&M Shuler Medical, Inc.
13 patents
- JAB Distributors
JAB Distributors, LLC
13 patents
- Jiangmen Foreign…
Jiangmen Foreign Trade Group Co., Ltd.
13 patents
- JL Audio
JL Audio, Inc.
13 patents
- JLS Automation
JLS Automation
13 patents
- John Bean AB
John Bean Technologies AB
13 patents
- Joint Stock “Atom…
Joint Stock Company “ATOMENERGOPROEKT”
13 patents
- Jiangsu Aosaikang… ◀
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
13 patents
What this shows Jiangsu holds 13 patents at rank #21,302, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Jiangsu
By rank, the assignees closest to #21,302 in granted patent volume.
- Isola USA Corp. #21,298 · 13 patents
- J&M Shuler Medical, Inc. #21,299 · 13 patents
- JAB Distributors, LLC #21,300 · 13 patents
- Jiangmen Foreign Trade Group Co., Ltd. #21,301 · 13 patents
- JL Audio, Inc. #21,303 · 13 patents
- JLS Automation #21,304 · 13 patents
- John Bean Technologies AB #21,305 · 13 patents
- Joint Stock Company “ATOMENERGOPROEKT” #21,306 · 13 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Jiangsu's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Jiangsu's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 44th percentile higher than 44% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 7.7% |
| 2020 | 3 | 23.1% |
| 2021 | 4 | 30.8% |
| 2022 | 2 | 15.4% |
| 2023 | 1 | 7.7% |
| 2024 | 1 | 7.7% |
| 2025partial year | 1 | 7.7% |
Which technologies does Jiangsu Aosaikang Pharmaceutical Co., Ltd. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 61.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #21,309 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Jiangsu Aosaikang Pharmaceutical Co., Ltd. against Isola USA Corp., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.